Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD and TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial
| dc.contributor.author | Lachmann, Helen | |
| dc.contributor.author | CALVO, Inmaculada | |
| dc.contributor.author | Frenkel, Joost | |
| dc.contributor.author | GATTORNO, Marco | |
| dc.contributor.author | HOFFMAN, Hal M. | |
| dc.contributor.author | KONE-PAUT, Isabelle | |
| dc.contributor.author | MOUTSCHEN, Michel | |
| dc.contributor.author | Ozen, Seza | |
| dc.contributor.author | QUARTIER, Pierre | |
| dc.contributor.author | SIMON, Anna | |
| dc.contributor.author | ZEFT, Andrew | |
| dc.contributor.author | LHERITIER, Karine | |
| dc.contributor.author | SPEZIALE, Antonio | |
| dc.contributor.author | JUNGE, Guido | |
| dc.contributor.author | DE BENEDETTI, Fabrizio | |
| dc.contributor.author | ANTON, Jordi | |
| dc.contributor.author | Ben-Chetrit, Eldad | |
| dc.contributor.author | Kasapcopur, Ozgur | |
| dc.date.accessioned | 2021-03-05T17:27:59Z | |
| dc.date.available | 2021-03-05T17:27:59Z | |
| dc.identifier.citation | DE BENEDETTI F., ANTON J., Ben-Chetrit E., CALVO I., Frenkel J., GATTORNO M., HOFFMAN H. M. , Kasapcopur O., KONE-PAUT I., Lachmann H., et al., "Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD and TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial", ARTHRITIS & RHEUMATOLOGY, cilt.69, ss.22-23, 2017 | |
| dc.identifier.issn | 2326-5191 | |
| dc.identifier.other | av_c5bdc3ed-4e78-47ae-ad9a-5a45048d8fa9 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/131099 | |
| dc.language.iso | eng | |
| dc.subject | Klinik Tıp | |
| dc.subject | ROMATOLOJİ | |
| dc.subject | Tıp | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | İmmünoloji ve Romatoloji | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Klinik Tıp (MED) | |
| dc.title | Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD and TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial | |
| dc.type | Makale | |
| dc.relation.journal | ARTHRITIS & RHEUMATOLOGY | |
| dc.contributor.department | , , | |
| dc.identifier.volume | 69 | |
| dc.identifier.startpage | 22 | |
| dc.identifier.endpage | 23 | |
| dc.contributor.firstauthorID | 42729 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
-
Makale [92796]
